Mike Cusnir

6PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2026
Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM).

|Apr 14, 2026
Real-World Data of R-mini-CHOP Therapy in Elderly Hispanic Population with Diffuse Large B-Cell Lymphoma and High-Grade Follicular Lymphoma.

Carla Romagnoli, Veronica Guerra, Leily Santos-Carrion

|Jun 02, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.

Theresa Medina, Jason A Chesney, Harriet M Kluger

|Dec 26, 2024
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.

Patrick M Boland, Heinz-Josef Lenz, Kristen K Ciombor

|Aug 08, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Aug 07, 2019
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.

Jason Willis, Martina I Lefterova, Alexander Artyomenko

Pageof 1

Frequent Collaborators

2 joint publications

Seung Tae Kim

1 joint publications

Patrick M Boland

1 joint publications

Heinz-Josef Lenz

1 joint publications

Kristen K Ciombor